INM

InMed Pharmaceuticals Inc.

Company with tickers: INM

CIK

1728328

CUSIP

457637700

Shares Outstanding

3,314,063

13F Activity (30d)

5 filings 5 filers

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value	After
2026-05-19	ADAR1 Capital Management, LLC	10% Owner	Buy	200,000	$1.56	$312,080	600,000
2026-05-19	ADAR1 Capital Management, LLC	10% Owner	Other	331,449	—	—	331,449
2026-05-19	ADAR1 Capital Management, LLC	10% Owner	Buy	200,000	$1.50	$299,800	800,000
2026-05-19	ADAR1 Capital Management, LLC	10% Owner	Buy	68,551	$1.60	$109,668	400,000
2025-12-19	Jagpal Netta	Chief Financial Officer	Award	18,000	—	—	24,250
2025-12-19	ADAMS ERIC A	Director, President & CEO	Award	35,000	—	—	49,050
2025-12-19	HSU ERIC C	Sr. VP, Pre-Clinical Res/Dev	Award	13,000	—	—	18,280
2025-12-19	Lemerond Nicole	Director	Award	1,750	—	—	2,725
2025-12-19	Bathery John Steven	Director	Award	1,750	—	—	5,250
2025-12-19	Johnson Shane Aaron	Sr VP & General Manager	Award	8,500	—	—	12,400
2025-12-19	Klompas Neil A	President & COO	Award	1,750	—	—	5,250
2025-12-19	WOUDENBERG MICHAEL	Chief Operating Officer	Award	18,000	—	—	25,445
2025-12-19	HULL ANDREW	Director	Award	1,750	—	—	2,711
2025-12-15	HULL ANDREW	Director	Other	14	—	—	961
2025-12-15	ADAMS ERIC A	Director, President & CEO	Other	250	—	—	14,050
2025-12-15	HSU ERIC C	Sr. VP, Pre-Clinical Res/Dev	Other	70	—	—	5,280
2025-12-15	WOUDENBERG MICHAEL	Chief Operating Officer	Other	60	—	—	7,445
2025-10-17	Klompas Neil A	President & COO	Award	3,500	—	—	3,500
2025-10-14	Bathery John Steven	Director	Other	0	—	—	0
2025-01-11	HULL ANDREW	Director	Other	2	—	—	975
2024-12-20	Johnson Shane Aaron	Sr VP & General Manager	Award	1,500	—	—	3,900
2024-12-20	HSU ERIC C	Sr. VP, Pre-Clinical Res/Dev	Award	2,750	—	—	5,350
2024-12-20	ADAMS ERIC A	Director, President & CEO	Award	6,250	—	—	14,300
2024-12-20	Baldasare Bryan T	Director	Award	550	—	—	975
2024-12-20	Jagpal Netta	Chief Financial Officer	Award	3,750	—	—	6,250
2024-12-20	Grove Janet P	Director	Award	550	—	—	975
2024-12-20	WOUDENBERG MICHAEL	Chief Operating Officer	Award	3,750	—	—	7,505
2024-12-20	Lemerond Nicole	Director	Award	550	—	—	975
2024-12-20	HULL ANDREW	Director	Award	550	—	—	977
2024-10-09	Klompas Neil A	President & COO	Other	0	—	—	0
2024-07-31	MANCINI ALEXANDRA DIANE JANET	Insider	Sell	240	$0.18	$42	0
2024-05-27	ADAMS ERIC A	Director, President & CEO	Other	1,139	—	—	161,000
2024-05-27	MANCINI ALEXANDRA DIANE JANET	Insider	Other	485	—	—	52,000
2024-05-27	WOUDENBERG MICHAEL	Chief Operating Officer	Other	394	—	—	75,100
2024-05-27	HSU ERIC C	Sr. VP, Pre-Clinical Res/Dev	Other	545	—	—	52,000
2024-03-04	HSU ERIC C	Sr. VP, Pre-Clinical Res/Dev	Other	309	—	—	52,545
2024-02-21	HULL ANDREW	Director	Buy	37,500	$0.39	$14,625	38,258
2024-02-20	Jagpal Netta	Chief Financial Officer	Other	0	—	—	0
2024-02-20	ADAMS ERIC A	Director, President & CEO	Buy	41,600	$0.36	$14,922	43,959
2024-01-21	MANCINI ALEXANDRA DIANE JANET	Insider	Other	121	—	—	52,485
2024-01-14	HULL ANDREW	Director	Other	42	—	—	8,542
2023-12-23	Lemerond Nicole	Director	Award	7,100	—	—	8,500
2023-12-23	Grove Janet P	Director	Award	7,100	—	—	8,500
2023-12-23	WOUDENBERG MICHAEL	Chief Operating Officer	Award	65,000	—	—	75,494
2023-12-23	Tegge Jonathan	Interim CFO	Award	30,000	—	—	31,400
2023-12-23	MANCINI ALEXANDRA DIANE JANET	Insider	Award	45,000	—	—	52,606
2023-12-23	Baldasare Bryan T	Director	Award	7,100	—	—	8,500
2023-12-23	HSU ERIC C	Sr. VP, Pre-Clinical Res/Dev	Award	45,000	—	—	52,854
2023-12-23	HULL ANDREW	Director	Award	7,100	—	—	8,584
2023-12-23	Johnson Shane Aaron	Sr VP & General Manager	Award	40,000	—	—	48,000

Showing 1–50 of 172 transactions